Olanzapine causes a leptin-dependent increase in acetylcholine release in mouse prefrontal cortex

Sleep

Volumn 35, Issue 3, 2012, Pages 315-323

  Wathen, Asheley B ^a   West, Emily S ^b   Lydic, Ralph ^b   Baghdoyan, Helen A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Atypical antipsychotics; B6.V Lep ob mouse; C57BL 6J mouse

Indexed keywords

ACETYLCHOLINE; LEPTIN; OLANZAPINE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; AROUSAL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELTA RHYTHM; DRUG POTENCY; DRUG TRANSPORT; ELECTROENCEPHALOGRAM; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; OSMOTIC PUMP; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; ELECTROENCEPHALOGRAPHY; LEPTIN; MALE; MICE; MICE, INBRED C57BL; PREFRONTAL CORTEX; WAKEFULNESS;

EID: 84858612219     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.1686     Document Type: Article

References (83)

1. Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005;10:79-104. (Pubitemid 40139590)
2. Cipriani A, Rendell J, Geddes JR. Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis. J Psychopharmacol 2010;24:1729-38.
3. Keck PE Jr. Bipolar depression: a new role for atypical antipsychotics? Bipolar Disord 2005;7 (Suppl 4):34-40.
4. Roth BL, Sheffler D, Potkin SG. Atypical antipsychotic drug actions: unitary or multiple mechanisms for 'atypicality'? Clin Neurosci Res 2003;3:108-17. (Pubitemid 36975299)
5. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. CMAJ 2005;172:1703-11. (Pubitemid 40896865)
6. Grootens KP, Van Veelen NMJ, Peuskens J, et al. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophr Bull 2011;37:352-61.
7. Pramyothin P, Khaodhiar L. Metabolic syndrome with the atypical anti-psychotics. Curr Opin Endocrinol Diabetes Obes 2010;17:460-6.
8. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Laurrabaquio MR. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 1999;46:141-3. (Pubitemid 29296829)
9. Sharpley AL, Attenburrow MEJ, Hafizi S, Cowen PJ. Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients. J Clin Psychiatry 2005;66:450-4. (Pubitemid 40593573)
10. Wichniak A, Szafranski T, Wierzbicka A, Waliniowska E, Jernajczyk W. Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment. J Psychopharmacol 2006;20:80-5.
11. Beasley CM, Tollefson GD, Tran PV. Safety of olanzapine. J Clin Psychiatry 1997;58[suppl 10]:13-7. (Pubitemid 27333175)
12. Sentissi O, Epelbaum J, Olie J-P, Poirier M-F. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull 2008;34:1189-99.
13. Harvey J. Leptin: a diverse regulator of neuronal function. J Neurochem 2007;100:307-13. (Pubitemid 46010992)
14. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950;41:317-8.
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32. (Pubitemid 24365442)
16. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2006;290:R894-903.
17. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir Physiol 2000;119:173-80. (Pubitemid 30155572)
18. ob mice differ in the cholinergic modulation of sleep and breathing. J Appl Physiol 2005;98:918-29.
19. Wang W, Baghdoyan HA, Lydic R. Leptin replacement restores supraspinal cholinergic antinociception in leptin-deficient obese mice. J Pain 2009;10:836-43.
20. Garcia-Rill E, Biedermann JA, Chambers T, et al. Mesopontine neurons in schizophrenia. Neuroscience 1995;66:321-35.
21. Karson CN, Garcia-Rill E, Biedermann J, Mrak RE, Husain MM, Skinner RD. The brain stem reticular formation in schizophrenia. Psychiatry Res 1991;40:31-48.
22. Garcia-Rill E. Disorders of the reticular activating system. Med Hypotheses 1997;49:379-87. (Pubitemid 27488012)
23. Zhou F-M, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 2001;4:1224-9. (Pubitemid 33135628)
24. Sarter M, Bruno JP. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci 1999;22:67-74. (Pubitemid 29125553)
25. Douglas CL, Baghdoyan HA, Lydic R. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse. J Pharmacol Exp Ther 2001;299:960-6. (Pubitemid 33104966)
26. Douglas CL, Baghdoyan HA, Lydic R. Prefrontal cortex acetylcholine release, EEG slow waves, and spindles are modulated by M2 autoreceptors in C57BL/6J mouse. J Neurophysiol 2002a;87:2817-22. (Pubitemid 34670661)
27. Douglas CL, Baghdoyan HA, Lydic R. Postsynaptic muscarinic M1 receptors activate prefrontal cortical EEG of C57BL/6J mouse. J Neurophysiol 2002b;88:3003-9. (Pubitemid 35448686)
28. Muzur A, Pace-Schott EF, Hobson JA. The prefrontal cortex in sleep. Trends Cogn Sci 2002;6:475-81. (Pubitemid 35341851)
29. 2A receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J Neurosci 2009;29:871-81.
30. National Academies Press. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academy of Sciences Press, 2011.
31. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. San Diego: Academic Press, 2001.
32. Fuster JM. The prefrontal cortex - an update: time is of the essence. Neuron 2001;30:319-33. (Pubitemid 32536780)
33. Groenewegen H, Uylings H. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 2000;126:3-28. (Pubitemid 35461278)
34. DeMarco GJ, Baghdoyan HA, Lydic R. Carbachol in the pontine reticular formation of C57BL/6J mouse decreases acetylcholine release in prefrontal cortex. Neuroscience 2004;123:17-29. (Pubitemid 37518472)
35. Flint RR, Chang T, Lydic R, Baghdoyan HA. GABAA receptors in the pontine reticular formation of C57BL/6J mouse modulate neurochemical, electrographic, and behavioral phenotypes of wakefulness. J Neurosci 2010;30:12301-9.
36. Bignall KE. Ontogeny of levels of neural organization: the righting reflex as a model. Exp Neurol 1974;42:566-73.
37. Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A 2008;105:1309-14. (Pubitemid 351397049)
38. Tung A, Szafran MJ, Bluhm B, Mendelson WB. Sleep deprivation potentiates the onset and duration of loss of righting reflex induced by propofol and isoflurane. Anesthesiology 2002;97:906-11.
39. Guan Z, Vgontzas AN, Bixler EO, Fang J. Sleep is increased by weight gain and decreased by weight loss in mice. Sleep 2008;31:627-33. (Pubitemid 351694251)
40. Vgontzas AN, Bixler EO, Basta M. Obesity and sleep: A bidirectional association? Sleep 2010;33:573-4.
41. Theorell-Haglow J, Bern C, Janson C, Sahlin C, Lindberg E. Association between short sleep duration and central obesity in women. Sleep 2010;33:583-8.
42. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62.
43. Van Cauter E, Spiegel K, Tasali E, Leproult R. Metabolic consequences of sleep and sleep loss. Sleep Med 2008;9 (Suppl 1):S23-8.
44. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care 2009;32:1980-5.
45. Muncey AR, Saulles AR, Koch LG, Britton SL, Baghdoyan HA, Lydic R. Disrupted sleep and delayed recovery from chronic peripheral neuropathy are distinct phenotypes in a rat model of metabolic syndrome. Anesthesiology 2010;113:1176-85.
46. Taheri S, Mignot E. Sleep well and stay slim: Dream or reality? Ann Intern Med 2010;153:475-6.
47. Lutter M, Nestler EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 2009;139:629-32.
48. Perello M, Chuang J-C, Scott MM, Lutter M. Translational neuroscience approaches to hyperphagia. J Neurosci 2010;30:11549-54.
49. Martin LE, Holsen LM, Chambers RJ, et al. Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity 2010;18:254-60.
50. Davids S, Lauffer H, Thoms K, et al. Increased dorsolateral prefrontal cortex activation in obese children during observation of food stimuli. Int J Obes (Lond) 2010;34:94-104.
51. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004;161:2126-9. (Pubitemid 39441418)
52. Uylings H, Van Eden C, De Bruin M, Feenstra M, Pennartz C, eds. Cognition, emotion and autonomic responses: the integrative role of the prefrontal cortex and limbic structures. Amsterdam: Elsevier, 2000.
53. Otani S, ed. Prefrontal cortex: from synaptic plasticity to cognition. Boston: Kluwer Academic, 2004.
54. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 2002;26:325-39. (Pubitemid 34159210)
55. Johnson DE, Nedza FM, Spracklin DK, et al. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. Eur J Pharmacol 2005;506:209-19. (Pubitemid 41071392)
56. Bymaster FP, Nelson DL, DeLapp NW, et al. Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro. Schizophr Res 1999;37:107-22. (Pubitemid 29167031)
57. Nguyen Q-T, Schroeder LF, Mank M, et al. An in vivo biosensor for neurotransmitter release and in situ receptor activity. Nat Neurosci 2010;13:127-34.
58. Müller MJ, Rossback W, Mann K, et al. Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms. Pharmacopsychiatry 2004;37:157-62. (Pubitemid 38916423)
59. Schuld A, Kühn M, Haak M, et al. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 2000;33:109-11. (Pubitemid 30346139)
60. Giménez S, Clos S, Romero S, Grasa E, Morte A, Barbanoj MJ. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers. Psychopharmacology 2007;190:507-16. (Pubitemid 46204468)
61. Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry 2000;47:468-70. (Pubitemid 30110618)
62. Azerinzky E, Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 1953;118:273-4.
63. Dement WC, Kleitman N. Cyclic variations in EEG during sleep and their relation to eye movements, body motility and dreaming. Electroenceph Clin Neurophysiol 1957;9:673-90.
64. Caldwell DF, Domino EF. Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients. Electroenceph Clin Neurophysiol 1967;22:414-20.
65. Jus K, Bouchard M, Jus AK, Villeneuve A, Lachance MA. Sleep EEG studies in untreated, long-term schizophrenic patients. Arch Gen Psychiatry 1973;29:386-90.
66. Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of sleep and wakefulness. Sleep Med Clin 2010;5:513-28.
67. Di Marco A, Demartis A, Gloaguen I, et al. Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin. Eur J Biochem 2000;267:2939-44. (Pubitemid 30321340)
68. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8. (Pubitemid 27289591)
69. Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007;356:237-47. (Pubitemid 46143227)
70. 1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci U S A 2007;104:3456-9.
71. Rodgers RJ, Ishii Y, Halford JCG, Blundell JE. Orexins and appetite regulation. Neuropeptides 2002;36:303-25. (Pubitemid 35440830)
72. Shemyakin A, Kapás L. L-364,718, a cholecystokinin-A receptor antagonist, suppresses feeding-induced sleep in rats. Am J Physiol Regul Integr Comp Physiol 2001;280:R1420-6.
73. Szentirmai E, Kapás L, Krueger JM. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 2007;292:R575-85. (Pubitemid 46089874)
74. Szentirmai E, Kapás L, Sun Y, Smith RG, Krueger JM. Spontaneous sleep and homeostatic sleep regulation in ghrelin knockout mice. Am J Physiol Regul Integr Comp Physiol 2007;293:R510-7. (Pubitemid 47092210)
75. Szentirmai E, Kapás L, Sun Y, Smith RG, Krueger JM. Restricted feeding- induced sleep, activity, and body temperature changes in normal and preproghrelin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2010;298:R467-77.
76. Szentirmai E, Kapás L, Sun Y, Smith RG, Krueger JM. The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice. Proc Natl Acad Sci U S A 2009;106:14069-74.
77. Rolls A, Schaich Borg J, de Lecea L. Sleep and metabolism: role of hypothalamic neuronal circuitry. Best Pract Res Clin Endocrinol Metab 2010;24:817-28.
78. Gur RE. Closing in on schizophrenia. Am J Psychiatry 2005;162:1783-4. (Pubitemid 41428608)
79. Ragland JD, Gur RC, Valdez JN, et al. Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition. Am J Psychiatry 2005;162:1840-8. (Pubitemid 41428613)
80. Tan H-Y, Choo W-C, Fones CSL, Chee MWL. fMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia. Am J Psychiatry 2005;162:1849-58. (Pubitemid 41428614)
81. Braun AR, Balkin TJ, Wesenten NJ, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H215O PET study. Brain 1997;120:1173-97. (Pubitemid 27285736)
82. Torigoe K, Nakahara K, Rahmadi M, et al. Usefulness of olanzapine as an adjunct to opioid treatment and for the treatment of neuropathic pain. Anesthesiology 2012;116:159-69.
83. Lett TAP, Wallace TJM, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry advance online publication, 6 September 2011; doi:10.1038/mp.2011.109